Cipta Sarana Medika Tbk. vs Indopoly Swakarsa Industry Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 23.35M 24h volume), while Indopoly Swakarsa Industry Tbk trades at Rp106 (market cap 689.44B, 231.3K 24h volume). The key difference: Indopoly Swakarsa Industry Tbk is far larger — about 4.3× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (23.35M versus 231.3K). Which is the better fit depends on your goals.
| DKHH | IPOL | |
|---|---|---|
Market Cap | 160.67B | 689.44B |
Volume | 23.35M | 231.3K |
Lot | 233.55K | 2.31K |
Turnover | 1.52B | 24.53M |
Average Price | 65.04 | 106.06 |
Value | 1.52B | 24.53M |
Indicative Equilibrium Price | 64 | 106 |
Indicative Equilibrium Volume | 1.35K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on IPOL →